Uncategorized pages
Jump to navigation
Jump to search
Showing below up to 100 results in range #51 to #150.
- (-)-Morphine
- (2S)-N-methyl-1-phenylpropan-2-amine
- (ACC/AHA) classification of the recommendations for patient evaluation and treatment
- (pyruvate dehydrogenase (acetyl-transferring))-phosphatase
- (s)-(+)-deoxyephedrine
- (s)-(+)-methamphetamine
- (s)-(+)-n,alpha,dimethylphenethylamine
- (s)-methamphetamine
- (s)-methylamphetamine
- (s)-n,alpha-dimethylbenzeneethanamine
- (s)-n,alpha-dimethylbenzeneethanoamine
- 1,4-butanediol
- 1-Octen-3-one
- 1-Phenyl-2-methylamino-propan
- 1-Phenyl-2-methylaminopropane
- 11β-hydroxylase deficiency
- 11β-hydroxylase deficiency (patient information)
- 11β-hydroxylase deficiency CT
- 11β-hydroxylase deficiency MRI
- 11β-hydroxylase deficiency causes
- 11β-hydroxylase deficiency classification
- 11β-hydroxylase deficiency history and symptoms
- 11β-hydroxylase deficiency laboratory findings
- 11β-hydroxylase deficiency medical therapy
- 11β-hydroxylase deficiency natural history, complications and prognosis
- 11β-hydroxylase deficiency other diagnostic studies
- 11β-hydroxylase deficiency other imaging findings
- 11β-hydroxylase deficiency pathophysiology
- 11β-hydroxylase deficiency physical examination
- 11β-hydroxylase deficiency prevention
- 11β-hydroxylase deficiency risk factors
- 11β-hydroxylase deficiency screening
- 11β-hydroxylase deficiency ultrasound
- 17-beta-hydroxysteroid dehydrogenase 3 deficiency overview
- 17 alpha-hydroxylase deficiency (patient information)
- 17 alpha-hydroxylase deficiency CT
- 17 alpha-hydroxylase deficiency MRI
- 17 alpha-hydroxylase deficiency causes
- 17 alpha-hydroxylase deficiency classification
- 17 alpha-hydroxylase deficiency differential diagnosis
- 17 alpha-hydroxylase deficiency historical perspective
- 17 alpha-hydroxylase deficiency history and symptoms
- 17 alpha-hydroxylase deficiency medical therapy
- 17 alpha-hydroxylase deficiency natural history, complications and prognosis
- 17 alpha-hydroxylase deficiency other diagnostic studies
- 17 alpha-hydroxylase deficiency other imaging findings
- 17 alpha-hydroxylase deficiency overview
- 17 alpha-hydroxylase deficiency pathophysiology
- 17 alpha-hydroxylase deficiency physical examination
- 17 alpha-hydroxylase deficiency prevention
- 17 alpha-hydroxylase deficiency risk factors
- 17 alpha-hydroxylase deficiency screening
- 17 alpha-hydroxylase deficiency surgery
- 17 alpha-hydroxylase deficiency ultrasound
- 18-Hydroxylase deficiency
- 1 E-5 m
- 2,5-dimethoxybenzaldehyde
- 2,6-di-tert-butyl-4-methylphenol
- 2-(4-chlorphenoxy)-ethanol
- 2-arachidonoylglycerol
- 2-phosphoglycerate
- 2007 WikiDoc Foundation Scholars
- 2009 SCAI Scientific Sessions Schedule
- 2017 ACC/AHA Hypertension Guidelines
- 2017 ACG guidelines for the indications to test for and to treat Helicobacter pylori infection
- 22q11.2 deletion syndrome
- 22q11.2 deletion syndrome historical perspective
- 2S-(+)-Methamphetamine
- 2b3a
- 3-center-2-electron bond
- 3 beta-hydroxysteroid dehydrogenase deficiency historical perspective
- 510K Pathway
- 6alpha-Methylprednisolone
- 8-Hydroxyquinoline
- 9,10-Didehydro-N,N-diethyl-6-methylergoline-8b-carboxamide
- A
- AAK
- ABCD guideline
- ACC-2017 Pregnancy - CHD
- ACC/AHA guidelines for cardiac radionuclide imaging (2003)
- ACC/AHA guidelines for dextro-transposition of great arteries
- ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 Appropriateness Criteria for Cardiac Magnetic Resonance Imaging
- ACC 2009 schedule
- ACC 2010 schedule
- ACC 2011 Schedule
- ACC 2012 schedule
- ACC 2013 schedule
- ACC 2014 schedule
- ACC AHA recommendations for surgery in adults with previous repair of tetralogy of fallot
- ACC Schedule 2015
- ACTH-secreting tumor
- ACTION
- ACTION ICU risk score
- ACTIVE A Trial
- ACT trial
- ADAM
- ADA guidelines classification scheme
- ADEPT
- ADMIRAL
- ADT